4//SEC Filing
MILESON GLENNA 4
Accession 0001209191-22-063009
CIK 0001620463other
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 4:58 PM ET
Size
7.4 KB
Accession
0001209191-22-063009
Insider Transaction Report
Form 4
MILESON GLENNA
Chief Financial Officer
Transactions
- Award
Common Stock
2022-11-18$2.74/sh+763$2,091→ 109,930 total - Purchase
Common Stock
2022-12-28$2.85/sh+50,000$142,250→ 159,930 total
Footnotes (4)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Athira Pharma, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the ESPP Purchase Period (as defined in the ESPP) of May 18, 2022 through November 18, 2022. This transaction is also exempt under Rule 16b-3(c).
- [F2]The Purchase Period ended November 18, 2022 and is the sole Purchase Period in the Offering Period (as defined in the ESPP) that began May 18, 2022.
- [F3]In accordance with the ESPP, these shares were purchased based on 85% of the closing price on November 18, 2022.
- [F4]The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.93 to $2.98, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.
Documents
Issuer
Athira Pharma, Inc.
CIK 0001620463
Entity typeother
Related Parties
1- filerCIK 0001822241
Filing Metadata
- Form type
- 4
- Filed
- Dec 29, 7:00 PM ET
- Accepted
- Dec 30, 4:58 PM ET
- Size
- 7.4 KB